Lamivudine and Zidovudine

Product NDC
55700-096
11-digit product format
557000096
Labeler code
55700
Product ID
55700-096_a4f4fad5-6dfe-41ef-b426-b6c96d3d8c3f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lamivudine and Zidovudine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Lake Erie Medical DBA Quality Care Products LLC
Application
ANDA202418
Marketing category
ANDA
Marketing start
2012-05-15
Marketing end
0000-00-00
Substance
LAMIVUDINE; ZIDOVUDINE
Active strength
150 mg/1; mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
55700-096-06EA - Each55700-096b579fdaf-8e5a-4576-a0da-2b51305ff0eb12016-12-07